NasdaqGM - Nasdaq Real Time Price USD
Zentalis Pharmaceuticals, Inc. (ZNTL)
At close: November 5 at 4:00 PM EST
Pre-Market: 7:01 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-166,377.0000
-207,822.0000
-163,751.0000
-154,093.0000
-86,825.0000
Investing Cash Flow
-63,476.0000
-44,458.0000
-114,180.0000
-18,115.0000
-284,832.0000
Financing Cash Flow
325.0000
237,303.0000
261,043.0000
178,521.0000
360,439.0000
End Cash Position
39,657.0000
30,719.0000
45,696.0000
62,584.0000
56,271.0000
Income Tax Paid Supplemental Data
--
140.0000
12.0000
20.0000
18.0000
Capital Expenditure
-485.0000
-583.0000
-2,548.0000
-6,107.0000
-758.0000
Issuance of Capital Stock
566.0000
237,303.0000
261,043.0000
179,667.0000
342,015.0000
Free Cash Flow
-166,862.0000
-208,405.0000
-166,299.0000
-160,200.0000
-87,583.0000
12/31/2020 - 4/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EPIX ESSA Pharma Inc.
1.7000
+4.29%
AVTE Aerovate Therapeutics, Inc.
2.7000
-0.74%
NGNE Neurogene Inc.
64.40
-2.42%
LYEL Lyell Immunopharma, Inc.
1.2400
-2.36%
XLO Xilio Therapeutics, Inc.
1.3100
-9.03%
CCCC C4 Therapeutics, Inc.
6.09
-5.58%
STRO Sutro Biopharma, Inc.
3.8400
+4.07%
ALGS Aligos Therapeutics, Inc.
9.83
+3.69%
ALXO ALX Oncology Holdings Inc.
1.5200
+2.01%
ZVSA ZyVersa Therapeutics, Inc.
2.5400
+38.80%